Search details
1.
ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins.
Mod Pathol
; 36(7): 100147, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36828362
2.
GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.
J Pathol
; 257(2): 158-171, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35072947
3.
Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer.
Cancer Immunol Immunother
; 71(4): 943-951, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34533610
4.
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer.
Mod Pathol
; 34(6): 1185-1193, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33462368
5.
PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.
Histopathology
; 78(2): 327-333, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32740981
6.
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.
Mod Pathol
; 32(10): 1544-1550, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31028363
7.
Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images.
Mol Cancer Res
; 22(4): 347-359, 2024 Apr 02.
Article
in English
| MEDLINE | ID: mdl-38284821
8.
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers.
Eur J Cancer
; 185: 105-118, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36972661
9.
Clonal relationships of adjacent Gleason pattern 3 and Gleason pattern 5 lesions in Gleason Scores 3+5=8 and 5+3=8.
Hum Pathol
; 130: 18-24, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36309296
10.
An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss.
Nat Commun
; 13(1): 6808, 2022 11 10.
Article
in English
| MEDLINE | ID: mdl-36357396
11.
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma.
Eur Urol Oncol
; 5(1): 113-117, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34049847
12.
Mismatch repair-deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade.
Cold Spring Harb Mol Case Stud
; 7(4)2021 08.
Article
in English
| MEDLINE | ID: mdl-34140335
13.
Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate Biopsies.
J Mol Diagn
; 23(8): 1030-1041, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34062284
14.
Well-differentiated neuroendocrine tumors of the lower urinary tract: biologic behavior of a rare entity.
Hum Pathol
; 109: 53-58, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33301750
15.
Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes.
Nat Commun
; 12(1): 935, 2021 02 10.
Article
in English
| MEDLINE | ID: mdl-33568675
16.
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
Eur Urol
; 80(6): 746-757, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-33785256
17.
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer.
Eur J Cancer
; 147: 74-83, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33626496
18.
Significance of Paneth cell-like differentiation in prostatic adenocarcinoma: a retrospective cohort study of 80 cases.
Hum Pathol
; 102: 7-12, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32445653
19.
Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort.
Hum Pathol
; 98: 74-80, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32119879
20.
Genomic and Clinicopathologic Characterization of ATM-deficient Prostate Cancer.
Clin Cancer Res
; 26(18): 4869-4881, 2020 09 15.
Article
in English
| MEDLINE | ID: mdl-32694154